MedTrace Logo

German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation

NCT06313944 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-11-26

No results posted yet for this study

Summary

This study will primarily investigate the safety and secondarily the effect and applicability of Transcranial Pulse Wave Stimulation (TPS) for the treatment of Alzheimer's disease in the context of a PMCF study (Post-Market Clinical Follow-up). The multicenter, prospective data collection should help to optimize the stimulation protocol, as well as to record frequent to occasional adverse effects of the product and cognitive, affective and subjective scores.

Conditions

  • Alzheimer Disease

Interventions

DIAGNOSTIC_TEST

Registry

Clinical data collection of patients scheduled for on-label treatment

Sponsors & Collaborators

  • Storz Medical AG

    collaborator INDUSTRY

  • Heinrich-Heine University, Duesseldorf

    lead OTHER

Principal Investigators

  • Lars Wojtecki, Prof. Dr. · Heinrich-Heine-Universität

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-06
Primary Completion
2026-10-01
Completion
2026-10-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06313944 on ClinicalTrials.gov